ArticleFrontiers in microbiomes2025
Microbial hallmarks of the respiratory tract in lung cancer: a meta-analysis.
Article in Frontiers in microbiomes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Microbiome as a prediction of immunotherapy response in lung cancer.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Introduction: Lung cancer is a leading cause of cancer-related deaths and has been associated with the microbiota of the human respiratory tract. However, the optimal sample type for studying the role of microbiota in lung cancer and the microbial hallmarks of lung cancer patients remain unclear. Methods: In this study, we downloaded 16S rRNA sequencing data of 1,105 high-quality samples from 13 BioProjects, including lung tissues, bronchoalveolar lavage (BAL) fluids, and saliva, and performed a meta-analysis. Results: Our results revealed that the BAL microbiota, dominated by taxa such as Discussion: These findings highlight distinct microbial patterns linked to lung cancer in the respiratory tract. More pronounced differences were observed in the BAL microbiota between healthy individuals and lung cancer patients, with the predominance of taxa, typically not abundant in the oral microbiota, serving as hallmarks of health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.